Pfizer Inc.
COMBINATIONS OF TGF-BETA INHIBITORS AND CDK INHIBITORS FOR CANCER TREATMENTS
Last updated:
Abstract:
This invention relates to a method of treating breast cancer by administering a TGF.beta. inhibitor in combination with a CDK inhibitor to a patient in need therof.
Status:
Application
Type:
Utility
Filling date:
16 Sep 2019
Issue date:
11 Nov 2021